Abstract
Current treatments of neurological and neurodegenerative diseases are limited due to the lack of a truly noninvasive, transient, and regionally selective brain drug delivery method. The brain is particularly difficult to deliver drugs to because of the blood–brain barrier (BBB). The impermeability of the BBB is due to the tight junctions between adjacent endothelial cells and highly regulatory transport systems of the endothelial cell membranes. The main function of the BBB is ion and volume regulation to ensure the conditions necessary for proper synaptic and axonal signaling. However, the same permeability properties that keep the brain healthy also present tremendous obstacles to its pharmacological treatment. Until a solution to the trans-BBB delivery problem is found, treatments of neurological diseases will remain impeded. Over the past decade, methods that combine focused ultrasound (FUS) and microbubbles have been shown to offer the unique capability to noninvasively, locally, and transiently open the BBB. Four of the main challenges to the application of FUS are (1) to assess its safety profile, (2) to unveil the mechanism by which the BBB opens and closes, (3) to control and predict the opened BBB properties and duration of the opening, and (4) to assess its promise for brain drug delivery. In this chapter, we discuss all of these challenges, along with findings in both small (mice) and large (nonhuman primates) animals, and emphasize the clinical potential for this technique.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte-endothelial interactions at the blood–brain barrier. Nat Rev Neurosci 7:41–53
Arvanitis CD, Livingstone MS, Vykhodtseva N, McDannold N (2012) Controlled ultrasound-induced blood–brain barrier disruption using passive acoustic emissions monitoring. PloS One 7(9):e45783
Bakay L, Ballantine HT Jr, Hueter TF, Sosa D (1956) Ultrasonically produced changes in the blood–brain barrier. AMA Arch Neurol Psychiatry 76:457–467
Ballantine HT Jr, Bell E, Manlapaz J (1960) Progress and problems in the neurological applications of focused ultrasound. J Neurosurg 17:858–876
Baseri B, Choi JJ, Tung YS, Konofagou EE (2010) Safety assessment of blood–brain barrier opening using focused ultrasound and definity microbubbles: a short-term study. Ultrasound Med Biol 36(9):1445–1459
Baseri B, Choi JJ, Deffieux T, Samiotaki G, Tung YS, Olumolade O, Small SA, Morrison B, Konofagou EE (2012) Activation of signaling pathways following localized delivery of systemically administered neurotrophic factors across the blood–brain barrier using focused ultrasound and microbubbles. Phys Med Biol 57(7):N65–N81
Blasberg RG, Patlak C, Fenstermacher JD (1975) Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusion. J Pharmacol Exp Ther 195:73–83
Borden M, Kruse D, Caskey C et al (2005) Influence of lipid shell physicochemical properties on ultrasound-induced microbubble destruction. IEEE Trans Ultrason Ferroelect Freq Contr 52:1992–2002
Burgess A, Ayala-Grosso CA, Ganguly M, Jordão JF, Aubert I, Hynynen K (2011) Targeted delivery of neural stem cells to the brain using MRI-guided focused ultrasound to disrupt the blood–brain barrier. PLoS One 6(11):e27877
Chen S, Kroll MH, Shohet RV, Frenkel P, Mayer SA, Grayburn PA (2002) Bioeffects of myocardial contrast microbubble destruction by echocardiography. Echocardiagraphy 19:495–500
Choi JJ, Pernot M, Small SA, Konofagou EE (2005) Feasibility of transcranial, localized drug-delivery in the brain of Alzheimer's-model mice using focused ultrasound. IEEE Inter Ultrason Symp, Boston, MA, 988–991
Choi JJ, Pernot M, Small S, Konofagou EE (2006) Noninvasive blood–brain barrier opening in live mice. International symposium on therapeutic ultrasound. AIP conference proceedings, vol 829:271–275
Choi JJ, Small SA, Konofagou EE (2006) Optimization of blood–brain barrier opening in mice using focused ultrasound, In: IEEE proceedings of the symposium in ultrasonics, ferroelectrics and frequency control, pp 540–543
Choi JJ, Pernot M, Small SA, Konofagou EE (2007a) Noninvasive, transcranial and localized opening of the blood–brain barrier using focused ultrasound in mice. Ultrasound Med Biol 33:95–104
Choi JJ, Pernot M, Brown TR, Small SA, Konofagou EE (2007b) Spatio-temporal analysis of molecular delivery through the blood–brain barrier using focused ultrasound. Phys Med Biol 52:5509–5530
Choi JJ, Wang S, Morrison B III, Konofagou EE (2007) Focused ultrasound-induced molecular delivery through the blood-brain barrier. In: IEEE proceedings of the symposium in ultrasonics, ferroelectrics and frequency control, New York, NY, pp 1192–1195
Choi JJ, Wang S, Brown TR, Small SA, Duff KE, Konofagou EE (2008) Noninvasive and transient blood–brain barrier opening in the hippocampus of Alzheimer's double transgenic mice using focused ultrasound. Ultrason Imaging 30:189–200
Choi JJ, Feshitan JA, Wang S, Tung Y-S, Baseri B, Borden MA, Konofagou EE (2009) The dependence of the ultrasound-induced blood–brain barrier opening characteristics on microbubble size in vivo. In: Emad SE (ed) 8th international symposium on therapeutic ultrasound. AIP, Minneapolis, MN, USA, pp 58–62
Choi J, Selert K, Vlachos F, Wong A, Konofagou EE (2011a) Noninvasive and localized neuronal delivery using short ultrasonic pulses and microbubbles. Proc Natl Acad Sci U S A 108(40):16539–16544
Choi J, Selert K, Gao Z, Samiotaki G, Baseri B, Konofagou EE (2011b) Noninvasive and localized blood-brain barrier disruption using focused ultrasound can be achieved at short pulse lengths and low pulse repetition frequencies. Journal of Cerebral Flow and Metabolism, 31(2), 725–737
Christensen DA (1988) Ultrasonic bioinstrumentation. Wiley, New York
Christiansen J, French BA, Klibanov AL, Kaul S, Lindner JR (2003) Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med Biol 29:1759–1767
Chomas JE, Dayton P, May D, Ferrara K (2001) Threshold of fragmentation for ultrasonic contrast agents. J Biomed Opt 6:141–150
Deffieux T, Konofagou E (2010) Numerical study and experimental validation of a simple transcranial focused ultrasound system applied to blood–brain barrier opening. IEEE Trans Ultrason Ferroelectr Freq Control 57(12):2637–2653
Farny CH, Holt RG, Roy RA (2009) Temporal and spatial detection of HIFU-induced inertial and hot-vapor cavitation with a diagnostic ultrasound system. Ultrasound Med Biol 35:603–615
Feshitan JA, Chen CC, Kwan JJ, Borden MA (2009) Microbubble size isolation by differential centrifugation. J Colloid Interface Sci 329:316–324
Fischer H, Gottschlich R, Seelig A (1998) Blood–brain barrier permeation: molecular parameters governing passive diffusion. J Membr Biol 165:201–211
Fung LK, Shin M, Tyler B, Brem H, Saltzman WM (1996) Chemotherapeutic drugs released from polymers: distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain. Pharmaceut Res 13:671–682
Ghose AK, Viswanadhan VN, Wendoloski JJ (1999) A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1:55–68
Howles GP, Bing KF, Qi Y, Rosenzweig SJ, Nightingale KR, Johnson GA (2010) Contrast-enhanced in vivo magnetic resonance microscopy of the mouse brain enabled by noninvasive opening of the blood–brain barrier with ultrasound. Magn Reson Med 64(4):995–1004
Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA (2001) Noninvasive MR imaging-guided focal opening of the blood–brain barrier in rabbits. Radiology 220:640–646
Hynynen K, McDannold N, Vykhodtseva N, Jolesz FA (2003) Non-invasive opening of BBB by focused ultrasound. Acta Neurochir Suppl 86:555–558
Hynynen K, McDannold N, Sheikov NA, Jolesz FA, Vykhodtseva N (2005) Local and reversible blood–brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonications. Neuroimage 24:12–20
Hynynen K, McDannold N, Vykhodtseva N, Raymond S, Weissleder R, Jolesz FA, Sheikov N (2006) Focal disruption of the blood–brain barrier due to 260-kHz ultrasound bursts: a method for molecular imaging and targeted drug delivery. J Neurosurg 105:445–454
Iadecola C (2004) Neurovascular regulation in the normal brain and in Alzheimer's disease. Nat Rev Neurosci 5:347–360
Kaps M, Seidel G, Algermissen C, Gerriets T, Broillet A (2001) Pharmacokinetics of echocontrast agent infusion in a dog model. J Neuroimaging 11:298–302
Kaufmann BA, Wei K, Lindner JR (2007) Contrast echocardiography. Curr Probl Cardiol 32:51–96
Kinoshita M, McDannold N, Jolesz FA, Hynynen K (2006) Noninvasive localized delivery of Herceptin to the mouse brain by MRI-guided focused ultrasound-induced blood–brain barrier disruption. Proc Natl Acad Sci U S A 103:11719–11723
Konofagou EE, Choi J, Baseri B, Lee A (2009) Characterization and optimization of trans-blood-brain barrier diffusion in vivo. In: Ebbini SE (ed) 8th international symposium on therapeutic ultrasound. AIP, Minneapolis, MN, USA, pp 418–422
Konofagou EE, Choi JJ (2008) Ultrasound-induced treatment of neurodegenerative diseases across the blood–brain barrier. In: Ahmed A-J, Alizad A (eds) Biomedical applications of vibration and acoustics in therapy, bioeffects and modeling. ASME Press, New York, NY, pp 63–80
Leighton RG (1997) The acoustic bubble. Academic, London, UK
Li P, Armstrong WF, Miller DL (2004) Impact of myocardial contrast echocardiography on vascular permeability: comparison of three different contrast agents. Ultrasound Med Biol 30:83–91
Li P, Cao LQ, Dou CY, Armstrong WF, Miller D (2003) Impact of myocardial contrast echocardiography on vascular permeability: an in vivo dose response study of delivery mode, pressure amplitude and contrast dose. Ultrasound Med Biol 29:1341–1349
Lipinski CA (2000) Drug-like properties and the causes of poor solubility and poor permeability. J Pharmacol Toxicol Methods 44:235–249
Liu GYP, Tan K et al (2005) Impact of microbubble enhanced ultrasound on blood–brain barrier permeability: an in vivo dose response study of ultrasound intensity and contrast dose. Circulation 112:U602–U605
Marquet F, Tung Y-S, Konofagou EE (2010) Feasibility study of a clinical blood–brain opening ultrasound system. Nano Life 1(3 & 4):309–322
Marquet F, Tung YS, Teichert T, Ferrera VP, Konofagou EE (2011) Noninvasive, transient and selective blood–brain barrier opening in non-human primates in vivo. PLoS One 6(7):e22598
McDannold N, Vykhodtseva N, Jolesz FA, Hynynen K (2004) MRI investigation of the threshold for thermally induced blood–brain barrier disruption and brain tissue damage in the rabbit brain. Magn Reson Med 51:913–923
McDannold N, Vykhodtseva N, Raymond S, Jolesz FA, Hynynen K (2005) MRI-guided targeted blood–brain barrier disruption with focused ultrasound: histological findings in rabbits. Ultrasound Med Biol 31:1527–1537
McDannold N, Vykhodtseva N, Hynynen K (2006) Targeted disruption of the blood–brain barrier with focused ultrasound: association with cavitation activity. Phys Med Biol 51:793–807
McDannold N, Arvanitis CD, Vykhodtseva N, Livingstone MS (2012) Temporary disruption of the blood–brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques. Cancer Res 72(14):3652–632012
Mesiwala AH, Farrell L, Wenzel HJ, Silbergeld DL, Crum LA, Winn HR, Mourad PD (2002) High-intensity focused ultrasound selectively disrupts the blood–brain barrier in vivo. Ultrasound Med Biol 28:389–400
Miller DL (2007) Overview of experimental studies of biological effects of medical ultrasound caused by gas body activation and inertial cavitation. Progr Biophys Mol Biol 93:314–330
Miller D, Li P, Dou C, Gordon D, Edwards CA, Armstrong WF (2005) Influence of contrast agent dose and ultrasound exposure on cardiomyocyte injury induced by myocardial contrast echocardiography in rats. Radiology 237:137–143
Neppiras EA (1980) Acoustic cavitation. Phys Rep 61:159–251
Patrick JT, Nolting MN, Goss SA, Dines KA, Clendenon JL, Rea MA, Heimburger RF (1990) Ultrasound and the blood–brain barrier. Adv Exp Med Biol 267:369–381
Pardridge WM (2005) The blood–brain barrier: bottleneck in brain drug development. NeuroRx 2:3–14
Pardridge WM (2006) Molecular trojan horses for blood–brain barrier drug delivery. Discov Med 6:139–143
Pardridge WM (2007) Drug targeting to the brain. Pharm Res 24:1733–1744
Raymond SB, Treat LH, Dewey JD, McDannold NJ, Hynynen K, Bacskai BJ (2008) Ultrasound enhanced delivery of molecular imaging and therapeutic agents in Alzheimer's disease mouse models. PLoS One 3(5):e2175
Samiotaki G, Vlachos F, Tung YS, Konofagou EE (2012) A quantitative pressure and microbubble-size dependence study of focused ultrasound-induced blood–brain barrier opening reversibility in vivo using MRI. Magn Reson Med 67(3):769–777
Sheikov N, McDannold N, Vykhodtseva N, Jolesz F, Hynynen K (2004) Cellular mechanisms of the blood–brain barrier opening induced by ultrasound in presence of microbubbles. Ultrasound Med Biol 30:979–989
Sheikov N, McDannold N, Jolesz F, Zhang YZ, Tam K, Hynynen K (2006) Brain arterioles show more active vesicular transport of blood-borne tracer molecules than capillaries and venules after focused ultrasound-evoked opening of the blood–brain barrier. Ultrasound Med Biol 32:1399–1409
Sheikov N, McDannold N, Sharma S, Hynynen K (2008) Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med Biol 34(7):1093–1104
Stewart PA, Tuor UI (1994) Blood-eye barriers in the rat: correlation of ultrastructure with function. J Comp Neurol 340:566–576
Treat LH, McDannold N, Vykhodtseva N, Zhang Y, Tam K, Hynynen K (2007) Targeted delivery of doxorubicin to the rat brain at therapeutic levels using MRI-guided focused ultrasound. Int J Cancer 121:901–907
Tung YS, Vlachos F, Choi JJ, Deffieux T, Selert K, Konofagou EE (2010) In vivo noninvasive cavitation threshold detection during blood–brain barrier opening using FUS and Definity. Phys Med Biol 55(20):6141–6155
Tung YS, Marquet F, Teichert T, Ferrera V, Konofagou EE (2011a) Feasibility of noninvasive cavitation-guided blood–brain barrier opening using focused ultrasound and microbubbles in nonhuman primates. Appl Phys Lett 98(16):163704
Tung YS, Vlachos F, Feshitan JA, Borden MA, Konofagou EE (2011b) The mechanism of interaction between focused ultrasound and microbubbles in blood–brain barrier opening in mice. J Acoust Soc Am 130(5):3059–3067
Vlachos F, Tung Y, Konofagou EE (2010) Permeability assessment of the focused ultrasound-induced blood–brain barrier opening using dynamic contrast-enhanced MRI. Phys Med Biol 55:5451–5466
Vykhodtseva NI, Hynynen K, Damianou C (1995) Histologic effects of high intensity pulsed ultrasound exposure with subharmonic emission in rabbit brain in vivo. Ultrasound Med Biol 21:969–979
Wang S, Olumolade O, Osting S, Burger C, Konofagou EE (2013) Focused ultrasound induced blood-brain barrier opening in macromolecule delivery, 13th International Symposium on Therapeutic Ultrasound, Shanghai, China
Yang FY, Fu WM, Yang RS, Liou HC, Kang KH, Lin WL (2007) Quantitative evaluation of focused ultrasound with a contrast agent on blood–brain barrier disruption. Ultrasound Med Biol 33:1421–1427
Acknowledgements
The work shown here was performed by Yao-Sheng Tung, James Choi, Thomas Deffieux, Babak Baseri, Fabrice Marquet, and Fotios Vlachos, previously with the Ultrasound and Elasticity Imaging Laboratory of the Biomedical Engineering Department at Columbia. Collaborators on the microbubble studies were Jameel Feshitan and Mark Borden (currently at the University of Colorado-Boulder) and on the non-human primate studies were Tobias Techert and Vincent Ferrera (Columbia University). The research was supported by NIH R01 EB009041, NIH R21 EY018505, NSF CAREER 064471, the Kinetics Foundation and the Kavli Institute.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Konofagou, E.E. (2014). Emerging Engineering Technologies for Opening the BBB. In: Hammarlund-Udenaes, M., de Lange, E., Thorne, R. (eds) Drug Delivery to the Brain. AAPS Advances in the Pharmaceutical Sciences Series, vol 10. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9105-7_20
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9105-7_20
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9104-0
Online ISBN: 978-1-4614-9105-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)